Hsp70-Bag3 interactions regulate cancer-related signaling networks

Cancer Research

Volumn 74, Issue 17, 2014, Pages 4731-4740

  Colvin, Teresa A ^a   Gabai, Vladimir L ^a   Gong, Jianlin ^a   Calderwood, Stuart K ^b   Li, Hu ^c   Gummuluru, Suryaram ^a   Matchuk, Olga N ^d   Smirnova, Svetlana G ^d   Orlova, Nina V ^d   Zamulaeva, Irina A ^d   Garcia Marcos, Mikel ^a   Li, Xiaokai ^e   Young, Z T ^e   Rauch, Jennifer N ^e   Gestwicki, Jason E ^e   Takayama, Shinichi ^a   Sherman, Michael Y ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ELAVL1 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 72; HU ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; C57BL MOUSE; CELL LINE; EXPERIMENTAL MELANOMA; FEMALE; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; MCF 7 CELL LINE; MOUSE; NUDE MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HSP72 HEAT-SHOCK PROTEINS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MCF-7 CELLS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84907055560     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0747     Document Type: Article

References (48)

1. Michels AA, Kanon B, Konings AW, Ohtsuka K, Bensaude O, Kampinga HH. Hsp70 and Hsp40 chaperone activities in the cytoplasm and the nucleus of mammalian cells. J Biol Chem 1997; 272:33283-9.
2. Stege GJ, Li GC, Li L, Kampinga HH, Konings AW. On the role of hsp72 in heat-induced intranuclear protein aggregation. Int J Hyperthermia 1994;10:659-74.
3. Mosser DD, Morimoto RI. Molecular chaperones and the stress of oncogenesis. Oncogene 2004;23:2907-18.
4. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 2006;31:164-72.
5. Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 2011;30:2836-45.
6. Hunt CR, Dix DJ, Sharma GG, Pandita RK, Gupta A, Funk M, et al. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol Cell Biol 2004;24:899-911.
7. Wang Z, Gall JM, Bonegio RG, Havasi A, Hunt CR, Sherman MY, et al. Induction of heat shock protein 70 inhibits ischemic renal injury. Kidney Int 2011;79:861-70.
8. McConnell KW, Fox AC, Clark AT, Chang NY, Dominguez JA, Farris AB, et al. The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol 2011;186:3718-25.
9. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
10. Kim YN, Koo KH, Sung JY, Yun UJ, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012; 2012:306879.
11. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009;136:823-37.
12. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006;5:2592-601.
13. Beere H, Wolf B, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2: 469-75.
14. Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004;5:1-10.
15. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-33.
16. Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 2007;67:2373-81.
17. Gabai VL, Yaglom JA, Waldman T, Sherman MY. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 2009;29:559-69.
18. Rerole AL, Gobbo J, De Thonel A, Schmitt E, Pais de Barros JP, Hammann A, et al. Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res 2011;71:484-95.
19. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I, et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2006;2: 474-9.
20. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009;36:15-27.
21. Leu JI, Pimkina J, Pandey P, Murphy ME, George DL. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 2011;9:936-47.
22. Miyata Y, Rauch JN, Jinwal UK, Thompson AD, Srinivasan S, Dickey CA, et al. Cysteine reactivity distinguishes redox sensing by the heatinducible and constitutive forms of heat shock protein 70. Chem Biol 2012;19:1391-9.
23. Massey AJ, Williamson DS, Browne H, Murray JB, Dokurno P, Shaw T, et al. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol 2010;66:535-45.
24. Huryn DM, Brodsky JL, Brummond KM, Chambers PG, Eyer B, Ireland AW, et al. Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (Hsp70) modulators. Proc Natl Acad Sci U S A 2011;108:6757-62.
25. Rodina A, Patel PD, Kang Y, Patel Y, Baaklini I, Wong MJ, et al. Identification of an allosteric pocket on human hsp70 reveals a mode of inhibition of this therapeutically important protein. Chem Biol 2013;20:1469-80.
26. Takayama S, Reed JC. Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 2001;3:E237-41.
27. Ingham RJ, Colwill K, Howard C, Dettwiler S, Lim CS, Yu J, et al. WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol 2005;25:7092-106.
28. Li SS. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 2005;390(Pt 3):641-53.
29. Carra S, Seguin SJ, Lambert H, Landry J. HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator ofmacroautophagy. J Biol Chem2008;283:1437-44.
30. Ulbricht A, Eppler FJ, Tapia VE, van der Ven PF, Hampe N, Hersch N, et al. Cellular mechanotransduction relies on tension-induced and chaperone-assisted autophagy. Curr Biol 2013;23:430-5.
31. Gamerdinger M, Kaya AM, Wolfrum U, Clement AM, Behl C. BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins. EMBO Rep 2011;12:149-56.
32. Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA, et al. CAIR- 1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 2000;19:4385-95.
33. Iwasaki M, Homma S, Hishiya A, Dolezal SJ, Reed JC, Takayama S. BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 2007;67:10252-9.
34. Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC. CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res 2006;312:2962-71.
35. Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, et al. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 2011; 303:65-71.
36. Gentilella A, Khalili K. BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner. J Biol Chem 2011;286:9205-15.
37. Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, et al. IKK {gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A 2010;107:7497-502.
38. Chen Y, Yang LN, Cheng L, Tu S, Guo SJ, Le HY, et al. Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity. Mol Cell Proteomics 2013;12:2804-19.
39. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005;25:10875-94.
40. Halasi M, Gartel AL. FOX(M1) news - it is cancer. Mol Cancer Ther 2013;12:245-54.
41. Gabai VL, Meng L, Kim G, Mills TA, Benjamin IJ, Sherman MY. Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol Cell Biol 2012;32:929-40.
42. Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA 2010;1:214-29.
43. Rousaki A, Miyata Y, Jinwal UK, Dickey CA, Gestwicki JE, Zuiderweg ER. Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones. J Mol Biol 2011;411:614-32.
44. Wang AM, Miyata Y, Klinedinst S, Peng HM, Chua JP, Komiyama T, et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol 2013;9:112-8.
45. Chang L, Miyata Y, Ung PM, Bertelsen EB, McQuade TJ, Carlson HA, et al. Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism. Chem Biol 2011;18:210-21.
46. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D,WongJY, et al. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res 2002;62:1213-21.
47. Meltser V, Ben-Yehoyada M, Shaul Y. c-Abl tyrosine kinase in the DNA damage response: cell death and more. Cell Death Differ 2011;18:2-4.
48. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.